Zhang Yan

26PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Oct 28, 2026
Baseline Monoclonal Protein Identifies Plasmacytic Differentiation and Shorter Progression-Free Survival in Marginal Zone Lymphoma.

|May 04, 2026
Duodenal Lymphomas: Comprehensive Evaluation of Endoscopic Features and Clinical Outcomes in a Tertiary Center.

|Jun 24, 2025
Germline defects of familial haemophagocytic lymphohistiocytosis-Related genes may represent a predisposing factor for mature T- and natural killer-cell lymphoma.

Chong Wei, Yan Zhang, Danqing Zhao

|Jan 15, 2025
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma.

Wenjuan Yu, Ping Li, Lili Zhou

|Nov 26, 2024
Inflammation-Associated Coagulation Reactions are Associated with the Prognosis in Critically Ill Very Old Patients (VOPs) with Infection.

Hui Lian, Huacong Cai, Xiaoting Wang

|Jul 26, 2024
Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA.

Chao Chen, Yiao Di, Zhe Zhuang

Pageof 5

Frequent Collaborators

8 joint publications

Wei Wang

8 joint publications

Wei Zhang

8 joint publications

Wei Chong

6 joint publications

DaoBin Zhou